PICO

6 results

Comprehensive Analysis of Adverse Events Associated With SGLT2is: A Meta-Analysis Involving Nine Large Randomized Trials.

Qiu M, Zhao LM, Zhan ZL - Frontiers in endocrinology, December 21, 2021 7 citations

Lin and colleagues

I/C

sodium-glucose cotransporter 2 inhibitors (SGLT2is), use of SGLT2is vs. non-use

occurrences of various kinds of serious adverse events (AE)

Amoxicillin Is the Most Effective Oral Antibiotic Prophylaxis Regimen for Reducing Post-Invasive Dental Procedure Bacteremia.

Thornhill M - The journal of evidence-based dental practice, September 15, 2020 2 citations

Zeng BS, Lin SY, Tu YK, et al

I/C

Prevention of Postdental Procedure Bacteremia

J Dent Res 2019 Oct;98(11):1204-1210

Not all Desensitizing Toothpastes Perform Equally Well.

Balevi B - The journal of evidence-based dental practice, September 15, 2020 2 citations

Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM

I/C

Desensitizing Toothpastes

Dentine Hypersensitivity

Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer.

Li DF, Tulahong A, Uddin MN, Zhao H, Zhang H - Mathematical biosciences and engineering : MBE, September 15, 2021 2 citations

E2F4, FOXM1, TFDP1, E2F1, SIN3A, JUN, DDX4, FOSL1, NOC2L, HMGA1, CDK1, CCNB1, AURKA, CDC20, CCNA2, SCNN1A, CDCA3, SOX6

I/C

survival prognosis, immune infiltrations, diagnostic efficacy

Combined Orthodontic-Surgical Treatment May Be an Effective Choice to Improve Oral Health-Related Quality of Life for Individuals Affected With Severe Dentofacial Deformities.

Gandedkar NH, Darendeliler MA - The journal of evidence-based dental practice, September 15, 2020 4 citations

Orthodontic-surgical treatment patients

I/C

Conventional combined orthodontic-surgical treatment, No treatment or alternative treatments

Oral health-related quality of life

Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis.

Lv X, Qi J, Zhou M, Shi B, Cai C, Tang Y, Pan T, Han Y - Critical reviews in oncology/hematology, April 05, 2020 7 citations

8050 patients

I/C

Cyclosporine + methotrexate + Anti-T cell globulin (ATG), tacrolimus + methotrexate + ATG, tacrolimus + bortezomib + sirolimus, cyclosporine + marrow mesenchymal stem cells (MMSCs), corticosteroids alone

proportion of patients who respond to therapies

Papers